Larry Lin is a Senior Equity Analyst in Central Research at Columbia Threadneedle Investments and is responsible for the Therapeutics vertical. He joined Columbia Threadneedle in 2006. Previously, he worked as a Senior Research Analyst at Primarius Capital and Engemann Asset Management, focusing on healthcare. He has been a member of the investment community since 1998. He received a B.S. in Biomedical Engineering with a minor in Business Administration from the University of Southern California. In addition, he holds the CFA^® designation and is a member of the CFA Society of Portland.